Antitrust Antitrust

Former Advanz lawyer sets out antitrust compliance credentials as UK drug-pricing appeals kick off

By Simon Zekaria
  • 22 Nov 2022 17:39
  • 22 Nov 2022 17:46
Advanz Pharma's former top lawyer told a UK judge today that he was well versed in antitrust compliance in the opening exchanges in a trial of drugmakers' challenges to UK fines for unfair pricing kicked off.
Advanz Pharma, Allergan and other drugmakers as well as private equity firms are fighting

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Simon Zekaria

Senior Correspondent

Simon Zekaria is a senior correspondent in London, covering UK regulation. Prior to joining MLex, Simon reported on business news for The Wall Street Journal, including on telecommunications, media, technology and consumer affairs. Simon was also a writer for the WSJ on diverse subjects such as Brexit, UK politics and global sport. Simon was previously a correspondent on competition issues and European politics for Thomson Reuters and Agence France-Presse in Brussels. Simon is a graduate of Edinburgh University, with Masters degrees in literature and law. A French speaker, he has studied at the Sorbonne University, Paris.

Discover MLex

Stay on top of global regulatory developments

Latest News